|
Real-time Estimate
Cboe BZX
17:51:15 19/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 70.00 USD | +3.70% |
|
+3.27% | +0.56% |
| 07-31 | UBS Adjusts Exponent Price Target to $72 From $75, Maintains Neutral Rating | MT |
| 07-31 | Exponent, Inc., Q2 2026 Earnings Call, Jul 30, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 84 | +24.43% | 3 | ||||||
| 216.31 | +8.45% | 16 | ||||||
| 162.53 | +13.77% | 15 | ||||||
| 32.44 | +18.3% | 17 | ||||||
| 58.97 | +0.81% | 12 | ||||||
| 24.52 | +10.81% | 13 | ||||||
| 314.17 | +7.52% | 12 | ||||||
| 42.18 | +21.74% | 11 | ||||||
| 74.38 | +11.17% | 8 | ||||||
| 44.38 | +25.11% | 8 | ||||||
| - | 273.33 | -4.6% | 3 | |||||
| 74.79 | +8.73% | 14 | ||||||
| 150.5 | +37.9% | 2 | ||||||
| 2.041 | -1.99% | 8 | ||||||
| 1,350 | +15.93% | 5 | ||||||
| 3.138 | +19.48% | 12 | ||||||
| - | 50.27 | +9.28% | 3 | |||||
| 51.67 | -5.6% | 3 | ||||||
| - | 92.5 | +64.04% | 2 | |||||
| Average | 163.27 | +15.01% | 9 | ||||||
| Weighted average by Cap. | 169.85 | +11.58% | 13 |
- Stock Market
- Stocks
- EXPO Stock
- Sector Exponent, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
